You searched for "PPE"
A unique case of macular burn from ‘toy’ laser
The first laser was created in 1960 and its name is an acronym for ‘light amplification by stimulated emission of radiation’. Laser technology has been used for medical, industrial, research and entertainment purposes in a variety of fields following extensive...Pathophysiology of diabetic macular oedema: why combination therapy may be better
The prevalence of diabetes has continued to increase over the years. It is currently estimated that there are 382 million with diabetes worldwide in 2013, and that this figure is expected to rise to 592 million by 2035 [1]. In...RNIB’s pre-employment team wins ERSA Employability Award for tailored support
The Royal National Institute of Blind People (RNIB) has received an Employment Related Services Association (ERSA) award for its tailored support programme for blind and partially sighted people seeking work. Only one in four blind and partially sighted people of...Online submissions open for NCC contact lens congress
Online submissions for a collaborative research symposium to be held as part of Europe’s biggest eye health conference are now open.Updated Guidance for Professional Practice published by College of Optometrists
The College of Optometrists has today (11 December) published updated Guidance for Professional Practice for optometrists, including new sections.Teams start preparing for Optoversity Challenge 2025
Out of the Box Optic’s Optoversity Challenge – the exciting student competition and fundraiser for Vision Care for Homeless People – has opened the 2025 registration. Optometry schools are invited to propose a team for this easy-to-enter challenge which brings...
Fingolimod: ocular adverse effects
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
